Christopher J. Lindop, CFO & EVP Business Development at HAEMONETICS CORP (HAE), sold 68,628 shares at $42.50 ($2.9M) on 2013-06-18, disclosed to the SEC on 2013-06-20.
Scheduled sale ($2.9M) by CFO & EVP Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| HAE | SELL | 2015-08-24 | $189K | — | Filing → |
| HAE | SELL | 2015-07-21 | $192K | — | Filing → |
| HAE | SELL | 2015-06-23 | $208K | — | Filing → |